Get the Stockscreener App
2.2848
3.19%
-0.0752
Vivosim Labs Inc stock is traded at $2.2848, with a volume of 62,347.
It is down -3.19% in the last 24 hours and down -32.80% over the past month.
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
See More
Previous Close:
$2.36
Open:
$2.27
24h Volume:
62,347
Relative Volume:
0.09
Market Cap:
$6.01M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.21%
1M Performance:
-32.80%
6M Performance:
+14.24%
1Y Performance:
+0.00%
1-Day Range:
$2.21
$2.405
1-Week Range:
$2.21
$3.20
52-Week Range:
$1.41
$5.30
Vivosim Labs Inc Stock (VIVS) Company Profile
Name
Vivosim Labs Inc
Sector
Industry
Phone
858-224-1000
Address
11555 SORRENTO VALLEY ROAD, SAN DIEGO
Compare VIVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
2.31 | 6.14M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.00 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.77 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.83 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.63 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.76 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-18 | Initiated | H.C. Wainwright | Buy |
| Nov-10-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-25-17 | Initiated | Raymond James | Outperform |
| Aug-11-15 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| Jun-29-15 | Initiated | Jefferies | Buy |
| Jun-29-15 | Initiated | Piper Jaffray | Overweight |
View All
Vivosim Labs Inc Stock (VIVS) Latest News
Can machine learning forecast VivoSim Labs Inc. recoveryBond Market & Fast Entry and Exit Trade Plans - newser.com
How supply chain issues affect VivoSim Labs Inc. stockJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Will VivoSim Labs Inc. stock keep outperforming rivals2025 Sector Review & Stock Portfolio Risk Control - newser.com
What does recent volatility data suggest for VivoSim Labs Inc.Market Movers & Advanced Swing Trade Entry Plans - newser.com
Pattern recognition hints at VivoSim Labs Inc. upsideJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - newser.com
How VivoSim Labs Inc. stock reacts to job market data2025 Trading Volume Trends & Community Trade Idea Sharing - newser.com
Using RSI to spot recovery in VivoSim Labs Inc.2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com
Will VivoSim Labs Inc. (4OR) stock gain from lower interest ratesMarket Rally & Verified Momentum Stock Watchlist - newser.com
Will VivoSim Labs Inc. (4OR) stock beat revenue estimates2025 Retail Activity & Reliable Volume Spike Trade Alerts - newser.com
Is VivoSim Labs Inc. stock trading near support levels2025 Market Overview & Weekly High Potential Stock Alerts - newser.com
Does VivoSim Labs Inc. show high probability of rebound2025 Buyback Activity & Risk Controlled Stock Alerts - newser.com
Is VivoSim Labs Inc. still worth holding after the dipFed Meeting & Safe Capital Allocation Plans - newser.com
Will VivoSim Labs Inc. stock benefit from commodity pricesWeekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
Can VivoSim Labs Inc. (4OR) stock hit consensus price targetsQuarterly Investment Review & Real-Time Market Sentiment Alerts - newser.com
What valuation ratios show for VivoSim Labs Inc. (4OR) stockJuly 2025 Retail & Safe Swing Trade Setups - newser.com
Can trapped investors hope for a rebound in VivoSim Labs Inc.Trade Volume Summary & High Accuracy Investment Signals - newser.com
Is VivoSim Labs Inc. stock a bargain at current levelsJuly 2025 Levels & Low Risk Entry Point Guides - newser.com
Heatmap analysis for VivoSim Labs Inc. and competitorsJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com
How VivoSim Labs Inc. (4OR) stock trades in high volatilityWeekly Gains Summary & Free Technical Pattern Based Buy Signals - newser.com
Is VivoSim Labs Inc. reversing from oversold territoryPortfolio Performance Report & High Return Trade Guides - newser.com
Will earnings trigger a reversal in VivoSim Labs Inc.July 2025 Recap & Expert Approved Momentum Ideas - newser.com
Can VivoSim Labs Inc. stock resist market sell offs2025 Momentum Check & High Accuracy Swing Trade Signals - newser.com
Is VivoSim Labs Inc. stock a contrarian buyJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com
Relative strength of VivoSim Labs Inc. in sector analysisJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
Can a trend reversal in VivoSim Labs Inc. lead to recoveryIPO Watch & Community Verified Trade Signals - newser.com
Is VivoSim Labs Inc. forming a bottoming baseEarnings Overview Summary & AI Forecast Swing Trade Picks - newser.com
Can VivoSim Labs Inc. stock sustain free cash flow growth - newser.com
What insider trading reveals about VivoSim Labs Inc. stockJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Is VivoSim Labs Inc. stock overvalued by current metricsWeekly Volume Report & Verified Stock Trade Ideas - newser.com
Is VivoSim Labs Inc. stock safe for conservative investorsMarket Performance Report & Verified Momentum Watchlists - newser.com
How VivoSim Labs Inc. (4OR) stock performs during market turbulenceTrade Analysis Report & Reliable Entry Point Trade Alerts - newser.com
Vivosim Labs Inc Stock (VIVS) Financials Data
There is no financial data for Vivosim Labs Inc (VIVS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.14%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):